Gastric
& Breast Cancer
DOI: 10.2122/gbc.2005.0040
VIEWPOINT
|
The complexity in deciding for BRCA genetic testing ? insurance coverage and risks of missing young carriers by strict criteria
Rolex Replica Watches
Ioannis Georgiou, PhD, Michael Fatouros, MD, Ioannis Arampatzis, MD, Demosthenis Ziogas, MD, Evangelos Paraskevaidis, MD, Angelos M Kappas, MD, Dimitrios H Roukos, MD.
|
Abstract |
Criteria suggestive of hereditary breast ovarian cancer (HBOC) syndrome that warrant genetic testing are not consistent. The body of literature data is limited and evidence about cost-effectiveness of genetic testing is lacking. Insurance coverage of genetic testing among various countries is not clear and the thresholds (10 to 20%) of the probability for positive genetic testing considerably vary in the national recommendations from UK , US, Germany and Sweden .
Should more or less strict clinical criteria used for decisions about genetic testing? Considering the risk of missing a young BRCA carrier and the associated high risk of death for this woman on one hand and the high costs and insurance coverage of the other, we attempt to approach this key question. |
|
|
|
Find Delta Dental, MetLife Dental, Aetna Dentist, New York Dentist, San Francisco Dentist, Boston Dentist, Chicago Dentist, Los Angeles Dentist & San Diego Dentist at DoctorsImprovingHealthcare.org. Online
ISSN : 1109 - 7647
Print ISSN : 1109 - 7655
 We
subscribe to the HONcode principles. Verify
here.
please, read our policy about privacy
and confidentiality of information and transparency
of sponsorship
last
update: 3 February 2004 |
|
|
|
